Application 021202
- Type
- NDA
- Sponsor
- EMD SERONO INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | GLUCOPHAGE XR | METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
| 004 | GLUCOPHAGE XR | METFORMIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 750MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | Yes | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0087-6063 | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6063 | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6064 | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | Bristol-Myers Squibb Company | NDA | Current |
| 0087-6064 | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | Bristol-Myers Squibb Company | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 54396 | SUPPL | 2018-05-31 |
| 54382 | SUPPL | 2018-05-31 |
| 47946 | SUPPL | 2017-04-12 |
| 47945 | SUPPL | 2017-04-12 |
| 47936 | SUPPL | 2017-04-11 |
| 47935 | SUPPL | 2017-04-11 |
| 14628 | SUPPL | 2008-08-29 |
| 27051 | SUPPL | 2008-08-28 |
| 36336 | SUPPL | 2006-11-06 |
| 4628 | SUPPL | 2006-11-06 |
| 42018 | ORIG | 2004-06-04 |
| 4627 | SUPPL | 2004-03-24 |
| 4626 | SUPPL | 2004-03-24 |
| 4625 | SUPPL | 2003-04-18 |
| 14627 | SUPPL | 2003-04-17 |
| 4624 | SUPPL | 2002-01-08 |
| 4623 | SUPPL | 2001-04-19 |
| 14626 | ORIG | 2000-10-13 |
| 4622 | ORIG | 2000-10-13 |